rs782290433
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_000377.3(WAS):c.223G>A(p.Val75Met) variant causes a missense change. The variant allele was found at a frequency of 0.00000895 in 111,733 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: 𝑓 0.0000089 ( 0 hom., 0 hem., cov: 22)
Consequence
WAS
NM_000377.3 missense
NM_000377.3 missense
Scores
10
5
2
Clinical Significance
Conservation
PhyloP100: 5.46
Genes affected
WAS (HGNC:12731): (WASP actin nucleation promoting factor) The Wiskott-Aldrich syndrome (WAS) family of proteins share similar domain structure, and are involved in transduction of signals from receptors on the cell surface to the actin cytoskeleton. The presence of a number of different motifs suggests that they are regulated by a number of different stimuli, and interact with multiple proteins. Recent studies have demonstrated that these proteins, directly or indirectly, associate with the small GTPase, Cdc42, known to regulate formation of actin filaments, and the cytoskeletal organizing complex, Arp2/3. Wiskott-Aldrich syndrome is a rare, inherited, X-linked, recessive disease characterized by immune dysregulation and microthrombocytopenia, and is caused by mutations in the WAS gene. The WAS gene product is a cytoplasmic protein, expressed exclusively in hematopoietic cells, which show signalling and cytoskeletal abnormalities in WAS patients. A transcript variant arising as a result of alternative promoter usage, and containing a different 5' UTR sequence, has been described, however, its full-length nature is not known. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 16 ACMG points.
PM1
In a domain WH1 (size 109) in uniprot entity WASP_HUMAN there are 10 pathogenic changes around while only 0 benign (100%) in NM_000377.3
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.982
PP5
Variant X-48684373-G-A is Pathogenic according to our data. Variant chrX-48684373-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 265289.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-48684373-G-A is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WAS | NM_000377.3 | c.223G>A | p.Val75Met | missense_variant | 2/12 | ENST00000376701.5 | NP_000368.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WAS | ENST00000376701.5 | c.223G>A | p.Val75Met | missense_variant | 2/12 | 1 | NM_000377.3 | ENSP00000365891 | P2 |
Frequencies
GnomAD3 genomes AF: 0.00000895 AC: 1AN: 111682Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33838
GnomAD3 genomes
AF:
AC:
1
AN:
111682
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
33838
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000549 AC: 1AN: 182289Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 66823
GnomAD3 exomes
AF:
AC:
1
AN:
182289
Hom.:
AF XY:
AC XY:
0
AN XY:
66823
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Cov.: 32
GnomAD4 exome
Cov.:
32
GnomAD4 genome AF: 0.00000895 AC: 1AN: 111733Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33899
GnomAD4 genome
AF:
AC:
1
AN:
111733
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
33899
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ExAC
AF:
AC:
1
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Wiskott-Aldrich syndrome;C1839163:Thrombocytopenia 1;C1845987:X-linked severe congenital neutropenia Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago | Sep 17, 2021 | WAS NM_000377.2 exon 2 p.Val75Met (c.223G>A): This variant has been reported in the literature in >10 individuals with X-linked thrombocytopenia (Kolluri 1995 PMID:8528198 (using alternate nomenclature c.257G>A), Albert 2010 PMID:20173115, Leblebisatan 2011 PMID:27264129). This variant is present in 1/12157 African alleles in the Genome Aggregation Database (http://gnomad.broadinstitute.org/rs782290433). Please note, disease causing variants may be present in control databases at low frequencies, reflective of the general population and/or variable expressivity. This variant is present in ClinVar (Variation ID:265289). Evolutionary conservation and computational predictive tools suggest that this variant may impact the protein. In addition, functional studies have shown a deleterious effect of this variant (Albert 2010 PMID:20173115, Sarkar 2015 PMID:26261240). In summary, this variant is classified as pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2023 | This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 75 of the WAS protein (p.Val75Met). This variant is present in population databases (rs782290433, gnomAD 0.008%). This missense change has been observed in individuals with X-linked thrombocytopenia (XLT) (PMID: 8528198, 8528199, 8595430, 9326235, 11793485, 12969986, 15284122, 20173115, 21185603, 27264129, 28931895). It has also been observed to segregate with disease in related individuals. This variant is also known as c.257G>A. ClinVar contains an entry for this variant (Variation ID: 265289). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on WAS protein function. Experimental studies have shown that this missense change affects WAS function (PMID: 19817875, 26261240). For these reasons, this variant has been classified as Pathogenic. - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Feb 20, 2018 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Feb 19, 2016 | The V75M missense variant in the WAS gene has been reported previously in association with WAS-related disorders (Albert et al., 2010; Kolluri et al., 1995). Please note, the Kolluri paper uses alternative cDNA nomenclature and indicates the position of the G>A nucleotide substitution at c.257. The V75M variant was not observed at any significant frequency in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. This substitution occurs at a position within the WH1 domain that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Functional studies have shown that V75M causes a severe negative effect on WAS protein function by interfering with WAS SUMOylation (Sarkar et al., 2015). Missense variants in the same codon (V75L) and in nearby residues (C73R/Y, F74S, K76T, D77H/G) have been reported in the Human Gene Mutation Database in association with WAS-related disorders (Stenson et al., 2014), supporting the functional importance of this region of the protein. Therefore, this variant is pathogenic. - |
Thrombocytopenia 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | May 05, 2017 | Variant summary: The WAS c.223G>A (p.Val75Met) variant located in the WASP family, EVH1 domain (via InterPro) involves the alteration of a non-conserved nucleotide and 3/4 in silico tools (SNPsandGO not captured here due to low reliability index) predict a damaging outcome. Functional studies, Rajmohan_2009 and Sarkar_2015, indicate that the varaint does impact WAS protein functionality. This variant was found in 1/80511 control chromosomes at a frequency of 0.0000124, which does not exceed the estimated maximal expected allele frequency of a pathogenic WAS variant (0.0035355). The variant of interest has been reported in multiple affected individuals diagnosed with X-linked thrombocytopenia. In addition, a clinical diagnostic laboratory classifies this variant as pathogenic. Furthermore, additional variants affecting the same amino acid, c.223G>T (p.V75L), and surrounding, c.221T>C (p.F74S), c.227A>C (p.K76T), and c.218G>A (p.C73Y), have all been reported and classified as pathogenic, suggesting the variant resides in a mutational hotspot. Therefore, taking all available lines of evidence into consideration, the variant of interest has been classified as "pathogenic." - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Pathogenic
D;D
FATHMM_MKL
Benign
D
LIST_S2
Uncertain
D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
.;M
MutationTaster
Benign
D
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;D
REVEL
Pathogenic
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Polyphen
1.0
.;D
Vest4
0.81
MutPred
Loss of methylation at K76 (P = 0.0286);Loss of methylation at K76 (P = 0.0286);
MVP
MPC
1.6
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at